Skip to main content

Advertisement

SpringerLink
Log in

Time trends of cancer incidence and mortality in Catalonia during 1993–2007

  • Special Article
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Purpose

To describe time trends of cancer in Catalonia, Spain, during the period 1993–2007.

Methods/patients

Data have been provided by two population-based cancer registries, Girona and Tarragona, and the Catalan mortality registry. Cancer incidence in Catalonia has been estimated through modeling methods using data from these health structures.

Results

During 2003–2007, there were 20,042 cancer cases and 9,842 deaths per year among men and 13,673 new cancer cases and 5,882 deaths among women. The most frequent incident cancers among men were prostate (N = 4,258), lung (N = 3,021), colorectal (N = 3,007) and bladder (N = 2,238), whereas among women they were breast (N = 3,907), colorectal (N = 2,088), corpus uteri (N = 734) and lung (N = 527). During 1993–2007, age-standardized incidence rates (ASIRs) rose 1.2 % per year among men [prostate (6.3 %), testis (5.7 %), kidney (2.9 %), liver (2.2 %) and colorectal (2.1 %)]. ASIRs decreased for stomach (−2.9 %), oral cavity and pharynx (−2.8 %), larynx (−2.7 %) and esophagus (−2 %). Among women, ASIRs only rose for lung (5.2 %), kidney (3.1 %), oral cavity and pharynx (2.6 %) and thyroid (1.6 %). ASIRs decreased for corpus uteri (−2.3 %), stomach (−1.7 %) and ovary (−1.6 %). Cancer mortality decreased −1.3 % per year among men and −2.1 % among women during the same period.

Conclusion

Among men, the decrease of incidence/mortality of tobacco-related tumors was related to a reduction of smoking prevalence. Among women, the stabilization of breast cancer incidence and the rise of lung cancer incidence are similar to that observed in most European regions. These results allow assessing the effectiveness of public health strategies and they pose new frontiers for cancer control in Catalonia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.

    Article  PubMed  Google Scholar 

  2. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46(4):765–81.

    Article  CAS  PubMed  Google Scholar 

  3. Cleries R, Ribes J, Buxo M, Ameijide A, Marcos-Gragera R, Galceran J, et al. Bayesian approach to predicting cancer incidence for an area without cancer registration by using cancer incidence data from nearby areas. Stat Med. 2012;10(31):978–87.

    Article  Google Scholar 

  4. Ribes J, Cleries R, Buxo M, Ameijide A, Valls J, Gispert R. Predictions of cancer incidence and mortality in Catalonia to 2015 by means of Bayesian models]. Med Clin (Barc). 2008;131(Suppl 1):32–41.

    Article  PubMed  Google Scholar 

  5. Sanchez MJ, Payer T, De Angelis R, Larranaga N, Capocaccia R, Martinez C. Cancer incidence and mortality in Spain: estimates and projections for the period 1981–2012. Ann Oncol. 2010;05(Suppl 3:iii):30–6.

    Google Scholar 

  6. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M et al, editors. Cancer Incidence in Five Continents, Vol. IX. Lyon: IARC Scientific Publications; 2007.

  7. World Health Organization. International Classification of Diseases, ninth revision. Geneva: WHO; 1977.

    Google Scholar 

  8. World Health Organization. International Statistical Classification of Diseases and Related Health problems, tenth revision. Geneva: WHO; 1992.

    Google Scholar 

  9. Esteban L, Cleries R, Galvez J, Pareja L, Escriba JM, Sanz X, et al. REGSTATTOOLS: freeware statistical tools for the analysis of disease population databases used in health and social studies. BMC Public Health. 2013;13(1):201.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: gLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.

    Article  CAS  PubMed  Google Scholar 

  11. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–403.

    Article  CAS  PubMed  Google Scholar 

  12. Malvezzi M, Bertuccio P, Levi F, la Vecchia C, Negri E. European cancer mortality predictions for the year 2012. Ann Oncol. 2013;24(3):792–800.

    Article  CAS  PubMed  Google Scholar 

  13. Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61(6):1079–92.

    Article  PubMed  Google Scholar 

  14. Izquierdo A, Gispert R, Saladie F, Espinas JA. Analysis of cancer incidence, survival and mortality according to the main tumoral localizations, 1985–2019: breast cancer. Med Clin (Barc). 2008;131(Suppl 1):50–2.

    Article  PubMed  Google Scholar 

  15. Pollan M, Pastor-Barriuso R, Ardanaz E, Arguelles M, Martos C, Galceran J, et al. Recent changes in breast cancer incidence in Spain, 1980–2004. J Natl Cancer Inst. 2009;101(22):1584–91.

    Article  PubMed  Google Scholar 

  16. Cleries R, Martinez JM, Moreno V, Yasui Y, Ribes J, Borras JM. Predicting the change in breast cancer deaths in Spain by 2019: a Bayesian approach. Epidemiology. 2013;24(3):454–60.

    Article  PubMed  Google Scholar 

  17. Bosetti C, Bertuccio P, Levi F, Chatenoud L, Negri E, la Vecchia C. The decline in breast cancer mortality in Europe: an update (to 2009). Breast. 2012;21(1):77–82.

    Article  PubMed  Google Scholar 

  18. Ribes J, Navarro M, Cleries R, Esteban L, Pareja L, Binefa G, et al. Colorectal cancer mortality in Spain: trends and projections for 1985–2019. Eur J Gastroenterol Hepatol. 2009;21(1):92–100.

    Article  PubMed  Google Scholar 

  19. Borras JM, Pareja L, Peris M, Espinas JA. Analysis of cancer incidence, survival and mortality according to the main tumoral localizations, 1985–2019: colorectal cancer. Med Clin (Barc). 2008;131(Suppl 1):58–62.

    Article  PubMed  Google Scholar 

  20. Manchon-Walsh P, Borras JM, Espinas JA, Aliste L. Variability in the quality of rectal cancer care in public hospitals in Catalonia (Spain): clinical audit as a basis for action. Eur J Surg Oncol. 2011;37(4):325–33.

    Article  CAS  PubMed  Google Scholar 

  21. Malvezzi M, Bosetti C, Rosso T, Bertuccio P, Chatenoud L, Levi F, et al. Lung cancer mortality in European men: trends and predictions. Lung Cancer. 2013;80(2):138–45.

    Article  PubMed  Google Scholar 

  22. Borras JM, Pinol JL, Izquierdo A, Borras J. Analysis of cancer incidence, survival and mortality according to the main tumoral localizations, 1985–2019: lung cancer. Med Clin (Barc). 2008;131(Suppl 1):53–7.

    Article  PubMed  Google Scholar 

  23. Schiaffino A, Fernandez E, Kunst A, Borrell C, Garcia M, Borras JM, et al. Time trends and educational differences in the incidence of quitting smoking in Spain (1965–2000). Prev Med. 2007;45(2–3):226–32.

    Article  PubMed  Google Scholar 

  24. Lopez MJ, Fernandez E, Perez-Rios M, Martinez-Sanchez JM, Schiaffino A, Galan I, et al. Impact of the 2011 Spanish smoking ban in hospitality venues: indoor secondhand smoke exposure and influence of outdoor smoking. Nicotine Tob Res. 2013;15(5):992–6.

    Article  CAS  PubMed  Google Scholar 

  25. Ploeg M, Aben KK, Kiemeney LA. The present and future burden of urinary bladder cancer in the world. World J Urol. 2009;27(3):289–93.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Marcos-Gragera R, Vilar-Coromina N, Galceran J, Borras J, Cleries R, Ribes J, et al. Rising trends in incidence of cutaneous malignant melanoma and their future projections in Catalonia, Spain: increasing impact or future epidemic? J Eur Acad Dermatol Venereol. 2010;24(9):1083–8.

    CAS  PubMed  Google Scholar 

  27. Marcos-Gragera R, Pollan M, Chirlaque MD, Guma J, Sanchez MJ, Garau I, et al. Attenuation of the epidemic increase in non-hodgkin’s lymphomas in Spain. Ann Oncol. 2010;21(Suppl 3:iii):90–6.

    Google Scholar 

  28. Clèries R, Martínez JM, Escribà JM, Esteban L, Pareja L, Borràs JM, et al. Monitoring the decreasing trend of testicular cancer mortality in Spain during 2005–2019 through a Bayesian approach. Cancer Epidemiology. 2010;34(3):244–56.

    Article  PubMed  Google Scholar 

  29. Ribes J, Pareja L, Esteban L, Cleries R. Analysis of cancer incidence, survival and mortality according to the main tumoral localizations, 1985–2019: liver cancer. Med Clin (Barc). 2008;131(Suppl 1):83–7.

    Article  PubMed  Google Scholar 

  30. Bray F, Carstensen B, Moller H, Zappa M, Zakelj MP, Lawrence G, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev. 2005;14(9):2191–9.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was conducted within the framework of the Spanish Cancer Research Network (Red Temática de Investigación Cooperativa en Cáncer-RTICC) of the Carlos III Health Institute (Instituto de Salud Carlos III). Grants with reference number RD12/0036/0056; RD06/0020/0095; RD 06/020/0089. This study was also conducted within the Research Group–Catalan Cancer Registry [SGR 2009-2013] from the Agència de Gestió d’Ajuts Universitaris i de Recerca–AGAUR of the Catalan Government.

Conflict of interest

The authors declare that they have no conflict of interest related to the publication of this manuscript.

Author information

Authors and Affiliations

  1. Registre de Càncer de Catalunya, Pla Director d’Oncologia (GENCAT). IDIBELL, Hospital Duran i Reynals, Gran Via 199-203 1ª planta. L’Hospitalet de Llobregat, 08907, Barcelona, Spain

    R. Clèries, L. Esteban & J. Ribes

  2. Departament de Ciències Clíniques, Universitat de Barcelona, 08907, Barcelona, Spain

    R. Clèries & J. Ribes

  3. Registre de Càncer de Tarragona, Fundació Lliga Per a la Investigació i Prevenció del Càncer, Reus, Tarragona, Spain

    J. Borràs, M. Carulla & J. Galceran

  4. Departament de Medicina i Cirurgia, Universitat Rovira i Virgili, Reus, Tarragona, Spain

    J. Borràs

  5. Unitat d’Epidemiología i Registre de Càncer en Girona (UERCG), Institut d’Investigació Biomèdica Girona Josep Trueta (IDIBGI), Girona, Spain

    R. Marcos-Gragera, M. Buxó & Á. Izquierdo

  6. Institut Català d’Oncologia (ICO), Girona, Spain

    R. Marcos-Gragera, M. Buxó & Á. Izquierdo

  7. Departament d’Infermeria, Universitat de Girona (UdG), Girona, Spain

    R. Marcos-Gragera

  8. Departament de Salut, Servei d’Informació i Estudis (GENCAT), C/Travessera de les Corts 131-159. Pavelló Ave Maria, 08028, Barcelona, Spain

    A. Freitas, A. Puigdefàbregas & R. Gispert

Authors
  1. R. Clèries
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Esteban
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Borràs
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Marcos-Gragera
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Freitas
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Carulla
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Buxó
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A. Puigdefàbregas
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Á. Izquierdo
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. R. Gispert
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. J. Galceran
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. J. Ribes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Clèries.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 112 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clèries, R., Esteban, L., Borràs, J. et al. Time trends of cancer incidence and mortality in Catalonia during 1993–2007. Clin Transl Oncol 16, 18–28 (2014). https://doi.org/10.1007/s12094-013-1060-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-013-1060-y

Keywords

Search

Navigation